Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary antimicrobial susceptibility testing market from 2025–2034 with trusted insights from The Business Research Company
How Big Is The Veterinary Antimicrobial Susceptibility Testing Market Size Today And What Will Its Value Be At The End Of 2029?
The global market for veterinary antimicrobial susceptibility testing has experienced substantial expansion over the preceding years, projecting a rise from its 2024 valuation of $37.12 billion to an expected $39.63 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.7%; this upward trajectory during the historical period is attributable to several key factors including mounting environmental anxieties, the increasing need for personalized medical treatments, the adoption of the One Health framework, heightened public consciousness regarding animal health, and the overall expansion of healthcare services for companion animals.
Antimicrobial susceptibility testing within the veterinary sector is projected to experience substantial expansion in the years ahead, reaching a market valuation of $53.66 billion by 2029, driven by a compound annual growth rate (CAGR) of 7.9%; this upswing is fueled by efforts to combat antibiotic resistance, evolving governmental mandates, the consequences of worldwide health incidents, and an increase in the number of companion animals; key developments during this projection window encompass the introduction of novel testing methodologies, heightened focus from regulatory bodies, measures to manage diseases transferable between animals and humans, and the establishment of higher benchmarks within the animal husbandry sector.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp
Which Key Drivers Are Powering Growth In The Veterinary Antimicrobial Susceptibility Testing Market?
Anticipated increases in the frequency of diseases transferable between animals and humans are projected to boost the expansion of the market for veterinary antimicrobial susceptibility testing. Such zoonotic ailments are defined as communicable conditions capable of transmission across different species, encompassing movement to or from humans and animals. This escalating incidence of zoonoses necessitates procedures to identify and select optimal therapeutic agents for animals. Veterinary antimicrobial susceptibility testing assists in selecting the most effective pharmaceuticals for combating bacterial infections in veterinary patients through an examination of prior treatment records and related factors. As an illustration, data reported in July 2022 by the World Health Organization, citing a US governmental entity, indicated a 64 percent escalation in zoonotic occurrences within Africa. Moreover, these cross-species infectious threats are becoming more common globally and specifically within India, with such emerging human infectious diseases representing 60 percent of all cases, derived from 816 known zoonotic pathogens out of a total of 1407 identified human pathogens. Consequently, the mounting occurrence of zoonotic diseases serves as a key impetus for the advancement of the veterinary antimicrobial susceptibility testing sector.
Which Segment Categories Are Driving Maximum Growth In The Veterinary Antimicrobial Susceptibility Testing Market?
The veterinary antimicrobial susceptibility testing market covered in this report is segmented –
1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users
Subsegments:
1) By Disks And Plates: Antibiotic Disks, Agar Plates
2) By Culture Media: Selective Culture Media, General Purpose Media
3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents
4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems
What Key Trends Are Driving Growth In The Veterinary Antimicrobial Susceptibility Testing Market?
A significant emerging trend shaping the veterinary antimicrobial susceptibility testing industry is the continuous progress in technology. Leading firms within the animal health sector are concentrating their efforts on developing novel technological solutions to maintain their competitive standing. In recent times, the market has observed the incorporation of sophisticated imaging methods and analytical procedures aimed at achieving swifter, more dependable, and precise results in veterinary AST procedures. To illustrate, in March of 2022, bioMérieux, a biotechnology enterprise headquartered in France, secured 510(k) clearance from the FDA for its recently developed VITEK MS PRIME, a mass spectrometry identification platform utilizing MALDI-TOF technology. Following this FDA approval, the system became accessible for commercial use in territories that accept the CE mark, alongside the United States, providing swift and precise identification of infectious agents, which subsequently facilitates the initiation of more focused and timely antimicrobial treatment protocols.
Who Are The Leading Companies Driving The Veterinary Antimicrobial Susceptibility Testing Market?
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.
Download The Full Report Here:
Which Region Holds The Largest Share In The Veterinary Antimicrobial Susceptibility Testing Market Today?
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=8177&type=smp
Browse Through More Reports Similar to the Global Veterinary Antimicrobial Susceptibility Testing Market 2025, By The Business Research Company
Antimicrobial Susceptibility Testing Global Market Report 2025
Antimicrobial Medical Device Coatings Global Market Report 2025
Veterinary Laboratory Testing Services Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model